Jane A. Little, M.D.
Affiliations: | 1990-2000 | University of Minnesota, Twin Cities, Minneapolis, MN | |
| 2001-2006 | National Institutes of Health, Bethesda, MD | ||
| 2006-2011 | Albert Einstein College of Medicine, New York, New York, United States | ||
| 2011-2018 | Case Western Reserve University, Cleveland Heights, OH, United States | ||
| 2018- | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
hematologyWebsite:
https://www.med.unc.edu/medicine/directory/jane-little/Google:
"Jane A. Little"Bio:
Parents
Sign in to add mentor| Gordon D. Ginder | research assistant | University of Iowa (GenetiTree) | |
| Ann Dean | post-doc | National Institute of Diabetes and Digestive and Kidney Diseases (GenetiTree) | |
| Mark T. Gladwin | post-doc | NIH/NHLBI (Physiology Academic Tree) |
Children
Sign in to add trainee| Agnieszka D Czechowicz | research assistant | 1998-2003 | University of Minnesota & NIH |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Johnson S, Gordeuk VR, Machado R, et al. (2021) Exercise Induced Changes of Vital Signs in Adults with Sickle Cell Disease. American Journal of Hematology |
| Kucukal E, Man Y, Quinn E, et al. (2020) Red blood cell adhesion to ICAM-1 is mediated by fibrinogen and is associated with right-to-left shunts in sickle cell disease. Blood Advances. 4: 3688-3698 |
| Nouraie M, Ashley-Koch AE, Garrett ME, et al. (2020) Serum albumin is independently associated with higher mortality in adult sickle cell patients: Results of three independent cohorts. Plos One. 15: e0237543 |
| Kucukal E, Man Y, Hill A, et al. (2020) Whole blood viscosity and red blood cell adhesion: Potential biomarkers for targeted and curative therapies in sickle cell disease. American Journal of Hematology |
| Man Y, Kucukal E, An R, et al. (2020) Microfluidic assessment of red blood cell mediated microvascular occlusion. Lab On a Chip |
| Man Y, Goreke U, Kucukal E, et al. (2020) Leukocyte adhesion to P-selectin and the inhibitory role of Crizanlizumab in sickle cell disease: A standardized microfluidic assessment. Blood Cells, Molecules & Diseases. 83: 102424 |
| Farrell AT, Panepinto J, Desai AA, et al. (2019) End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings. Blood Advances. 3: 4002-4020 |
| Nouraie M, Little JA, Hildesheim M, et al. (2019) Validation of a composite vascular high risk profile for adult patients with sickle cell disease. American Journal of Hematology |
| Carden MA, Little J. (2019) Emerging non-genetic therapies for sickle cell disease. Haematologica |
| Sinha AA, Adusumilli T, Cohen HW, et al. (2019) Splenectomy is not associated with a higher tricuspid regurgitant jet velocity in people with sickle cell anemia. Pediatric Blood & Cancer. e27928 |